lung fibroblast cell lines ccd19 (ATCC)
Structured Review

Lung Fibroblast Cell Lines Ccd19, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 757 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lung fibroblast cell lines ccd19/product/ATCC
Average 97 stars, based on 757 article reviews
Images
1) Product Images from "A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development"
Article Title: A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development
Journal: Anti-Cancer Drugs
doi: 10.1097/CAD.0000000000001773
Figure Legend Snippet: The cytotoxic effects of SP09 on NSCLC cell lines and normal lung cells at 72 h. (a) MTT assay showed the cell viability of three EGFR -mutant and KRAS -mutant NSCLC cell lines (H1975, PC9, H1650, A549, H460, and H358), human normal lung epithelial cells (BEAS-2B) and human lung fibroblast cells (CCD19) treated with SP09 for 72 h, all data presented as mean ± SD ( n = 3), **** P < 0.0001, ** P < 0.01, * P < 0.05.
Techniques Used: MTT Assay, Mutagenesis